# IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients

> **NCT04544033** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 120 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** interleuken 6 level measurment
- **DIAGNOSTIC_TEST:** Interleukin-6 Gene-174C detection

## Key facts

- **NCT ID:** NCT04544033
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-05-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04544033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04544033, "IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04544033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*